Atlas Trials

Phase I, Dose Escalation Study of Decitabine

Clinical trial NCT02264873 · COMPLETED

Trial details

NCT number
NCT02264873
Sponsor
University of Florida
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
Start date
2014-10-01
Primary completion
2016-10-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.